文献速递乳腺癌放疗放疗物理与技术

左侧乳腺癌表面引导深吸气屏气放疗中的潜在陷阱与临床解决方案

A Potential Pitfall and Clinical Solutions in Surface-Guided Deep Inspiration Breath Hold Radiation Therapy for Left-Sided Breast Cancer.
PubMed 文献 · Adv Radiat Oncol · 2023-05-27

研究分析60例左侧乳腺癌表面引导放疗患者,其中20例为腹式深吸气屏气(A-DIBH,垂直胸廓抬高VCE≤5 mm)患者,40例为回顾性随机对照。A-DIBH患者从自由呼吸到深吸气屏气心脏剂量显著降低(P<.01),40例对照中6例(15%)存在VCE≤5 mm,作者认为应在SGRT流程中识别A-DIBH并采用腹部ROI或腹部替代信号监测。

要点

  • A-DIBH(VCE≤5 mm)患者占15%(6/40),需在SGRT流程中识别。
  • A-DIBH患者从自由呼吸到DIBH心脏剂量显著降低(P<.01)。
  • 作者建议用腹部ROI或腹部替代信号代替常规胸部ROI。

核心结论

  • A-DIBH(VCE≤5 mm)患者群体占15%(6/40),应在SGRT流程中识别并相应监测。
  • 应使用新的腹部ROI或腹部替代信号代替常规仅胸部ROI。
  • 应保留患者特异性DIBH以提高可重复性,确保心脏保护。

研究设计与样本

  • 分析60例接受SGRT治疗的左侧乳腺癌患者:20例A-DIBH(VCE≤5 mm)患者为前瞻性识别,40例对照为回顾性随机选取。
  • 模拟定位时在剑突周围放置运动替代信号,采集自由呼吸(FB)和DIBH CT。
  • SGRT治疗摆位时在CT胸壁表面定义ROI,基于替代信号的摆位作为备份。
  • 20例A-DIBH患者中10例采用容积旋转调强计划,10例采用切线计划,临床DIBH计划在FB CT上重新计算以比较心脏和肺的剂量参数。

主要发现

  • 20例A-DIBH患者中,VCE=3±2 mm,替代信号运动9±6 mm,腹部运动14±5 mm。
  • A-DIBH患者从FB到DIBH心脏剂量降低显著(P<.01):∆DMax=-8.4±9.8 Gy,∆D5%=-2.4±4.4 Gy,∆DMean=-0.6±0.9 Gy。
  • 40例对照患者中6例(15%)发现VCE≤5 mm。

临床怎么用

  • 作者认为应在SGRT流程中识别A-DIBH(VCE≤5 mm)患者并相应监测。
  • 作者建议使用新的腹部ROI或腹部替代信号代替常规仅胸部ROI。
  • 作者认为应保留患者特异性DIBH以提高可重复性,确保心脏保护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Deep inspiration breath hold (DIBH) is an effective technique to spare the heart in treating left-sided breast cancer. Surface-guided radiation therapy (SGRT) is increasingly applied in DIBH setup and motion monitoring. Patient-specific breathing behavior, either thoracically driven or abdominally driven (A-DIBH), should be unaltered, online identified, and monitored accordingly to ensure reproducible heart-sparing treatment. METHODS AND MATERIALS: Sixty patients with left-sided breast cancer treated with SGRT were analyzed: 20 A-DIBH patients with vertical chest elevation (VCE ≤ 5 mm) were prospectively identified, and 40 control patients were retrospectively and randomly selected for comparison. At simulation, both free-breathing (FB) and DIBH computed tomography (CT) were acquired, guided by a motion surrogate placed around the xiphoid process. For SGRT treatment setups, the region of interest (ROI) was defined on the CT chest surface, and the surrogate-based setup was a backup. For all 60 patients, the VCE was measured as the average of the FB-to-DIBH elevations at the breast and xiphoid process, together with abdominal elevation. In the 40-patient control group, A-DIBH patients (VCE ≤ 5 mm) were identified. Of the 20 A-DIBH patients, 10 were treated with volumetric modulated arc therapy plans, and 10 patients were treated with tangent plans. Clinical DIBH plans were recalculated on FB CT to compare maximum dose (DMax), 5% of the maximum dose (D5%), mean dose (DMean), and V30Gy, V20Gy, and V5Gy of the heart and lungs and their significance. RESULTS: In the 20 A-DIBH patients, VCE = 3 ± 2 mm, surrogate motion (9 ± 6 mm), and abdomen motion of 14 ± 5 mm are found. Heart dose reduction from FB to DIBH is significant (P < .01): ∆DMax = -8.4 ± 9.8 Gy, ∆D5% = -2.4 ± 4.4 Gy, and ∆DMean = -0.6 ± 0.9 Gy. Six out of 40 control patients (15%) are found to have VCE ≤ 5 mm. CONCLUSIONS: A-DIBH (VCE ≤ 5 mm) patient population is significant (15%), and they should be identified in the SGRT workflow and monitored accordingly. A new abdominal ROI or an abdominal surrogate should be used instead of the conventional chest-only ROI. Patient-specific DIBH should be preserved for higher reproducibility to ensure heart sparing.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zeng C, Fan Q, Li X, et al. A Potential Pitfall and Clinical Solutions in Surface-Guided Deep Inspiration Breath Hold Radiation Therapy for Left-Sided Breast Cancer. Adv Radiat Oncol. 2023. PMID: 38047221. doi:10.1016/j.adro.2023.101276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。